DiPaola RS - Search Results

1

Clinical and biological activity of soy protein powder supplementation in healthy male volunteers.

Goodin S, Shen F, Shih WJ, Dave N, Kane MP, Medina P, Lambert GH, Aisner J, Gallo M, DiPaola RS. Goodin S, et al. Among authors: dipaola rs. Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):829-33. doi: 10.1158/1055-9965.EPI-06-0882. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17416779

2

Abiraterone in prostate cancer: a new angle to an old problem.

Stein MN, Goodin S, Dipaola RS. Stein MN, et al. Among authors: dipaola rs. Clin Cancer Res. 2012 Apr 1;18(7):1848-54. doi: 10.1158/1078-0432.CCR-11-1805. Epub 2012 Mar 26. Clin Cancer Res. 2012. PMID: 22451619 Free PMC article. Review.

3

Effect of docetaxel in patients with hormone-dependent prostate-specific antigen progression after local therapy for prostate cancer.

Goodin S, Medina P, Capanna T, Shih WJ, Abraham S, Winnie J, Doyle-Lindrud S, Todd M, DiPaola RS. Goodin S, et al. Among authors: dipaola rs. J Clin Oncol. 2005 May 20;23(15):3352-7. doi: 10.1200/JCO.2005.11.111. Epub 2005 Feb 28. J Clin Oncol. 2005. PMID: 15738531 Clinical Trial.

4

A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer.

Goodin S, Rao KV, Kane M, Dave N, Capanna T, Doyle-Lindrud S, Engle E, Jin L, Todd M, DiPaola RS. Goodin S, et al. Among authors: dipaola rs. Cancer Chemother Pharmacol. 2005 Aug;56(2):199-204. doi: 10.1007/s00280-004-0980-1. Epub 2005 Apr 19. Cancer Chemother Pharmacol. 2005. PMID: 15838657 Clinical Trial.

5

Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma.

DiPaola RS, Chenven ES, Shih WJ, Lin Y, Amenta P, Goodin S, Shumate A, Capanna T, Cardiella M, Cummings KB, Aisner J, Todd MB. DiPaola RS, et al. Cancer. 2001 Oct 15;92(8):2065-71. doi: 10.1002/1097-0142(20011015)92:8<2065::aid-cncr1546>3.0.co;2-k. Cancer. 2001. PMID: 11596021 Clinical Trial.

6

Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer.

DiPaola RS, Zhang H, Lambert GH, Meeker R, Licitra E, Rafi MM, Zhu BT, Spaulding H, Goodin S, Toledano MB, Hait WN, Gallo MA. DiPaola RS, et al. N Engl J Med. 1998 Sep 17;339(12):785-91. doi: 10.1056/NEJM199809173391201. N Engl J Med. 1998. PMID: 9738085 Free article.

7

Transdermal estradiol in castrate and chemotherapy resistant prostate cancer.

Stein M, Goodin S, Doyle-Lindrud S, Silberberg J, Kane M, Metzger D, Eddy S, Shih W, DiPaola RS. Stein M, et al. Among authors: dipaola rs. Med Sci Monit. 2012 Apr;18(4):CR260-4. doi: 10.12659/msm.882626. Med Sci Monit. 2012. PMID: 22460098 Free PMC article. Clinical Trial.

8

A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer.

Rao K, Goodin S, Levitt MJ, Dave N, Shih WJ, Lin Y, Capanna T, Doyle-Lindrud S, Juvidian P, DiPaola RS. Rao K, et al. Among authors: dipaola rs. Prostate. 2005 Feb 1;62(2):115-22. doi: 10.1002/pros.20130. Prostate. 2005. PMID: 15389797 Clinical Trial.

9

State-of-the-art treatment of metastatic hormone-refractory prostate cancer.

Goodin S, Rao KV, DiPaola RS. Goodin S, et al. Among authors: dipaola rs. Oncologist. 2002;7(4):360-70. doi: 10.1634/theoncologist.7-4-360. Oncologist. 2002. PMID: 12185298 Free article. Review.

10

Overcoming bcl-2- and p53-mediated resistance in prostate cancer.

DiPaola RS, Aisner J. DiPaola RS, et al. Semin Oncol. 1999 Feb;26(1 Suppl 2):112-6. Semin Oncol. 1999. PMID: 10190792 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page